staurosporine has been researched along with Bacterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YS; Chen, PH; Chen, YT; Chu, TY; Lin, HH; Lo, SJ; Ma, TH; Tan, BC; Wu, MH | 1 |
| Asami, Y; Crump, A; Ōmura, S | 1 |
1 review(s) available for staurosporine and Bacterial Disease
| Article | Year |
|---|---|
Staurosporine: new lease of life for parent compound of today's novel and highly successful anti-cancer drugs.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Carbazoles; Drug Discovery; Furans; Humans; Imatinib Mesylate; Neoplasms; Protein Kinase Inhibitors; Staurosporine | 2018 |
1 other study(ies) available for staurosporine and Bacterial Disease
| Article | Year |
|---|---|
Nucleolar control by a non-apoptotic p53-caspases-deubiquitinylase axis promotes resistance to bacterial infection.
Topics: Animals; Apoptosis; Bacterial Infections; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Nucleolus; Chromosomal Proteins, Non-Histone; Deubiquitinating Enzymes; HeLa Cells; Humans; Microscopy, Fluorescence; Pseudomonas Infections; RNA Interference; Staphylococcal Infections; Staurosporine; Tumor Suppressor Protein p53; Ubiquitin; Ubiquitin Thiolesterase | 2020 |